MayTech Global Investments’s CVS Health CVS Stock Holding History

MayTech Global Investments’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,675	Closed	-$156K	–	39
2022 Q4	$156K	Buy	+1,675	New	+$162K	0.05%	36
2022 Q3	–	Sell	-1,675	Closed	-$155K	–	42
2022 Q2	$155K	Hold	1,675	–	–	0.05%	42
2022 Q1	$170K	Hold	1,675	–	–	0.04%	43
2021 Q4	$173K	Hold	1,675	–	–	0.03%	44
2021 Q3	$142K	Hold	1,675	–	–	0.03%	41
2021 Q2	$140K	Buy	+1,675	New	+$137K	0.03%	40

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

MayTech Global Investments's CVS Position: Q1 2023 in Review

MayTech Global Investments sold out of CVS Health (CVS) in Q1 2023, closing a stake of 1,675 shares — an estimated $156K sold.

MayTech Global Investments first reported a position in CVS in Q2 2021 and held it in 6 quarters. The position peaked at $173K in Q4 2021. 2,267 funds tracked by Wall St. Rank hold CVS as of Q1 2023.

MayTech Global Investments reported no remaining CVS Health position as of Q1 2023 after selling out during the quarter.
MayTech Global Investments sold 1,675 CVS Health shares in Q1 2023, an estimated $156K.
MayTech Global Investments first reported a position in CVS Health in Q2 2021 and held it in 6 quarters.
MayTech Global Investments's CVS Health position peaked at $173K in Q4 2021.
2,267 funds tracked by Wall St. Rank held CVS Health as of Q1 2023.

Based on MayTech Global Investments's 13F filing for Q1 2023, filed 11 May 2023.